Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects.
Peixoto A, Pinto P, Guerra J, Pinheiro M, Santos C, Pinto C, Santos R, Escudeiro C, Bartosch C, Canário R, Barbosa A, Gouveia A, Petiz A, Abreu MH, Sousa S, Pereira D, Silva J, Teixeira MR.
Peixoto A, et al. Among authors: gouveia a.
Front Oncol. 2020 Jul 31;10:1318. doi: 10.3389/fonc.2020.01318. eCollection 2020.
Front Oncol. 2020.
PMID: 32850417
Free PMC article.